Selected research
Industry Growth & Trends
Global Oligonucleotide Array Industry Growth and Trends Forecast to 2032
Market perspective
The global Oligonucleotide Array market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oligonucleotide Array is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oligonucleotide Array include Illumnia, Affymetrix, Agilent Technologies, Roche NimbleGen, Sengenics, Arrayit, Applied Microarrays, Biometrix Technology and Savyon Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oligonucleotide Array market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oligonucleotide Array market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oligonucleotide Array market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oligonucleotide Array.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oligonucleotide Array market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oligonucleotide Array Market by Company
Illumnia
Affymetrix
Agilent Technologies
Roche NimbleGen
Sengenics
Arrayit
Applied Microarrays
Biometrix Technology
Savyon Diagnostics
Scienion AG
WaferGen
Oligonucleotide Array Segment by Type
Long Oligonucleotide Chip
Short Oligonucleotide Chip
Oligonucleotide Array Segment by Application
Gene Expression
Genotyping
Others
Oligonucleotide Array Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Array market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Array and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Array.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Array manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oligonucleotide Array in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Long Oligonucleotide Chip
- Short Oligonucleotide Chip
Applications
- Gene Expression
- Genotyping
- Others
Companies covered
- Illumnia
- Affymetrix
- Agilent Technologies
- Roche NimbleGen
- Sengenics
- Arrayit
- Applied Microarrays
- Biometrix Technology
- Savyon Diagnostics
- Scienion AG
- WaferGen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oligonucleotide Array Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oligonucleotide Array Sales Estimates and Forecasts (2021-2032)
- 1.3 Oligonucleotide Array Market by Type
- 1.3.1 Long Oligonucleotide Chip
- 1.3.2 Short Oligonucleotide Chip
- 1.4 Global Oligonucleotide Array Market Size by Type
- 1.4.1 Global Oligonucleotide Array Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oligonucleotide Array Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oligonucleotide Array Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oligonucleotide Array Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oligonucleotide Array Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oligonucleotide Array Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oligonucleotide Array Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oligonucleotide Array Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oligonucleotide Array Industry Trends
- 2.2 Oligonucleotide Array Industry Drivers
- 2.3 Oligonucleotide Array Industry Opportunities and Challenges
- 2.4 Oligonucleotide Array Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oligonucleotide Array Revenue (2021-2026)
- 3.2 Global Top Players by Oligonucleotide Array Sales (2021-2026)
- 3.3 Global Top Players by Oligonucleotide Array Price (2021-2026)
- 3.4 Global Oligonucleotide Array Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oligonucleotide Array Major Company Production Sites & Headquarters
- 3.6 Global Oligonucleotide Array Company, Product Type & Application
- 3.7 Global Oligonucleotide Array Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oligonucleotide Array Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oligonucleotide Array Players Market Share by Revenue in 2025
- 3.8.3 2025 Oligonucleotide Array Tier 1, Tier 2, and Tier 3
4 Oligonucleotide Array Regional Status and Outlook
- 4.1 Global Oligonucleotide Array Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oligonucleotide Array Historic Market Size by Region
- 4.2.1 Global Oligonucleotide Array Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oligonucleotide Array Sales in Value by Region (2021-2026)
- 4.2.3 Global Oligonucleotide Array Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oligonucleotide Array Forecasted Market Size by Region
- 4.3.1 Global Oligonucleotide Array Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oligonucleotide Array Sales in Value by Region (2027-2032)
- 4.3.3 Global Oligonucleotide Array Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oligonucleotide Array by Application
- 5.1 Oligonucleotide Array Market by Application
- 5.1.1 Gene Expression
- 5.1.2 Genotyping
- 5.1.3 Others
- 5.2 Global Oligonucleotide Array Market Size by Application
- 5.2.1 Global Oligonucleotide Array Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oligonucleotide Array Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oligonucleotide Array Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oligonucleotide Array Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oligonucleotide Array Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oligonucleotide Array Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oligonucleotide Array Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oligonucleotide Array Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Illumnia
- 6.1.1 Illumnia Company Information
- 6.1.2 Illumnia Business Overview
- 6.1.3 Illumnia Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Illumnia Oligonucleotide Array Product Portfolio
- 6.1.5 Illumnia Recent Developments
- 6.2 Affymetrix
- 6.2.1 Affymetrix Company Information
- 6.2.2 Affymetrix Business Overview
- 6.2.3 Affymetrix Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Affymetrix Oligonucleotide Array Product Portfolio
- 6.2.5 Affymetrix Recent Developments
- 6.3 Agilent Technologies
- 6.3.1 Agilent Technologies Company Information
- 6.3.2 Agilent Technologies Business Overview
- 6.3.3 Agilent Technologies Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Agilent Technologies Oligonucleotide Array Product Portfolio
- 6.3.5 Agilent Technologies Recent Developments
- 6.4 Roche NimbleGen
- 6.4.1 Roche NimbleGen Company Information
- 6.4.2 Roche NimbleGen Business Overview
- 6.4.3 Roche NimbleGen Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Roche NimbleGen Oligonucleotide Array Product Portfolio
- 6.4.5 Roche NimbleGen Recent Developments
- 6.5 Sengenics
- 6.5.1 Sengenics Company Information
- 6.5.2 Sengenics Business Overview
- 6.5.3 Sengenics Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sengenics Oligonucleotide Array Product Portfolio
- 6.5.5 Sengenics Recent Developments
- 6.6 Arrayit
- 6.6.1 Arrayit Company Information
- 6.6.2 Arrayit Business Overview
- 6.6.3 Arrayit Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Arrayit Oligonucleotide Array Product Portfolio
- 6.6.5 Arrayit Recent Developments
- 6.7 Applied Microarrays
- 6.7.1 Applied Microarrays Company Information
- 6.7.2 Applied Microarrays Business Overview
- 6.7.3 Applied Microarrays Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Applied Microarrays Oligonucleotide Array Product Portfolio
- 6.7.5 Applied Microarrays Recent Developments
- 6.8 Biometrix Technology
- 6.8.1 Biometrix Technology Company Information
- 6.8.2 Biometrix Technology Business Overview
- 6.8.3 Biometrix Technology Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Biometrix Technology Oligonucleotide Array Product Portfolio
- 6.8.5 Biometrix Technology Recent Developments
- 6.9 Savyon Diagnostics
- 6.9.1 Savyon Diagnostics Company Information
- 6.9.2 Savyon Diagnostics Business Overview
- 6.9.3 Savyon Diagnostics Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Savyon Diagnostics Oligonucleotide Array Product Portfolio
- 6.9.5 Savyon Diagnostics Recent Developments
- 6.10 Scienion AG
- 6.10.1 Scienion AG Company Information
- 6.10.2 Scienion AG Business Overview
- 6.10.3 Scienion AG Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Scienion AG Oligonucleotide Array Product Portfolio
- 6.10.5 Scienion AG Recent Developments
- 6.11 WaferGen
- 6.11.1 WaferGen Company Information
- 6.11.2 WaferGen Business Overview
- 6.11.3 WaferGen Oligonucleotide Array Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 WaferGen Oligonucleotide Array Product Portfolio
- 6.11.5 WaferGen Recent Developments
7 North America by Country
- 7.1 North America Oligonucleotide Array Sales by Country
- 7.1.1 North America Oligonucleotide Array Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oligonucleotide Array Sales by Country (2021-2026)
- 7.1.3 North America Oligonucleotide Array Sales Forecast by Country (2027-2032)
- 7.2 North America Oligonucleotide Array Market Size by Country
- 7.2.1 North America Oligonucleotide Array Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oligonucleotide Array Market Size by Country (2021-2026)
- 7.2.3 North America Oligonucleotide Array Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oligonucleotide Array Sales by Country
- 8.1.1 Europe Oligonucleotide Array Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oligonucleotide Array Sales by Country (2021-2026)
- 8.1.3 Europe Oligonucleotide Array Sales Forecast by Country (2027-2032)
- 8.2 Europe Oligonucleotide Array Market Size by Country
- 8.2.1 Europe Oligonucleotide Array Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oligonucleotide Array Market Size by Country (2021-2026)
- 8.2.3 Europe Oligonucleotide Array Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oligonucleotide Array Sales by Country
- 9.1.1 Asia-Pacific Oligonucleotide Array Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oligonucleotide Array Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oligonucleotide Array Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oligonucleotide Array Market Size by Country
- 9.2.1 Asia-Pacific Oligonucleotide Array Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oligonucleotide Array Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oligonucleotide Array Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oligonucleotide Array Sales by Country
- 10.1.1 South America Oligonucleotide Array Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oligonucleotide Array Sales by Country (2021-2026)
- 10.1.3 South America Oligonucleotide Array Sales Forecast by Country (2027-2032)
- 10.2 South America Oligonucleotide Array Market Size by Country
- 10.2.1 South America Oligonucleotide Array Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oligonucleotide Array Market Size by Country (2021-2026)
- 10.2.3 South America Oligonucleotide Array Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oligonucleotide Array Sales by Country
- 11.1.1 Middle East and Africa Oligonucleotide Array Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oligonucleotide Array Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oligonucleotide Array Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oligonucleotide Array Market Size by Country
- 11.2.1 Middle East and Africa Oligonucleotide Array Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oligonucleotide Array Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oligonucleotide Array Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oligonucleotide Array Value Chain Analysis
- 12.1.1 Oligonucleotide Array Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oligonucleotide Array Production Mode & Process
- 12.2 Oligonucleotide Array Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oligonucleotide Array Distributors
- 12.2.3 Oligonucleotide Array Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst